Haemolytic uraemic syndrome associated with OKT3.

Morris-Stiff, G; Evans, M; Baboolal, K; Balaji, V; Moore, R; Jurewicz, A; Lord, R

Morris-Stiff, G; Evans, M; Baboolal, K; Balaji, V; Moore, R; Jurewicz, A; Lord, R.

Transpl Int ; 9(5): 522-3, 1996.

Article in En | MEDLINE | ID: mdl-8875800

Subject(s)

Hemolytic-Uremic Syndrome/etiology; Immunosuppressive Agents/adverse effects; Muromonab-CD3/adverse effects; Postoperative Complications/etiology; Female; Hemolytic-Uremic Syndrome/immunology; Humans; Immunosuppressive Agents/therapeutic use; Ischemia/pathology; Kidney/blood supply; Kidney/pathology; Kidney Transplantation; Middle Aged; Tacrolimus/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Postoperative Complications / Muromonab-CD3 / Hemolytic-Uremic Syndrome / Immunosuppressive Agents Type of study: Risk_factors_studies Limits: Female / Humans / Middle aged Language: En Journal: Transpl Int Journal subject: TRANSPLANTE Year: 1996 Document type: Article Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links